MedTrace Logo

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

NCT04059536 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-07-21

No results posted yet for this study

Summary

The purpose of this registry study is to gather real world standard of care (SOC) data on the safety and performance on the Roxwood Medical catheter devices in the treatment of stenotic lesions and CTO.

Conditions

Interventions

DEVICE

Roxwood Anchoring Catheters

Anchoring catheters

DRUG

Acetylsalicylic Acid

Oral Tablet

DRUG

Heparin

Intravenous Injection

Sponsors & Collaborators

  • EKOS Corporation

    collaborator INDUSTRY

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas Davis, MD · Ascension St John

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2019-12-01
Completion
2020-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04059536 on ClinicalTrials.gov